Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Actavis completes acquisition of Allergan for $70.5bn Irish pharmaceutical firm Actavis has completed the acquisition of US-based Botox maker Allergan in a cash-and-stock deal valued at about $70.5bn. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

China FDA accepts for review WuXi MedImmune's IND for monoclonal antibody
By PBR Staff Writer
WuXi PharmaTech has announced that the China Food and Drug Administration (CFDA) has accepted to review WuXi MedImmune's investigational new drug (IND) application for new anti-IL6 monoclonal antibody for the treatment of rheumatoid arthritis.
News
EMA validates Biogen and AbbVie's MAA for Zinbryta to treat multiple sclerosis
By PBR Staff Writer
The European Medicines Agency (EMA) has validated Biogen and AbbVie's marketing authorisation application (MAA) for Zinbryta (daclizumab high-yield process), an investigational drug, to treat relapsing forms of multiple sclerosis (MS) in the European Union (EU).
News

OTC

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
News
Pharmax launches HLC Baby B and HLC Baby F probiotic supplements
By PBR Staff Writer
Pharmax, a business unit of Atrium Innovations, has introduced its new HLC Baby B and HLC Baby F probiotic supplements.
News

Manufacturing

Teva strengthens CNS franchise with $3.5bn acquisition of Auspex Pharma
By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries has agreed to acquire US-based Auspex Pharmaceuticals for about $3.5bn, in a move to strengthen its core central nervous system (CNS) franchise.
News
Novo Nordisk introduces hemophilia therapy Novoeight in US
By PBR Staff Writer
Danish pharmaceutical firm Novo Nordisk has introduced Novoeight (Antihemophilic Factor [Recombinant]) in the US for the treatment of people living with hemophilia A.
News